Scientific and Medical Advisors

• Don Mahuran, Ph.D., Genetics & Genome Biology
  • Mahuran recently retired as a Senior Scientist in the Research Institute of the Hospital for Sick Children (HSC) and a Professor in the department of Laboratory Medicine and Pathobiology at the University of Toronto, Canada.
  • His basic research carried out worldwide over the last forty years has made possible the development of novel therapeutic approaches for the treatment of several of lysosomal storage diseases.
  • He received his PhD from the University of Windsor, in Windsor, Ontario, Canada, completed his postdoctoral training at the Division of Neurosciences at The Hospital for Sick Children (SickKids).
• Claire Henchcliffe
  • Chair of University of California, Irvine (UCI) School of Medicine Department of Neurology.
  • She read for her BA in Biochemistry and completed her graduate thesis at the University of Oxford in the UK.
  • Post-doctoral training in genetics and neuroscience at the University of Cambridge, UK, and the University of California at Berkeley, California.
  • Dr. Henchcliffe received her medical degree from the College of Physicians and Surgeons of Columbia University in New York City. She completed both her internship and residency in neurology, and subsequently a fellowship in movement disorders at Columbia Presbyterian Medical Center’s Neurological Institute.
  • Her current research focuses on developing new treatments for Parkinson’s disease, and she has a specific interest in the potential for cell-based therapies.
  • She has been an investigator and on the steering committees for multiple clinical trials in Parkinson’s disease, and is the Weill Cornell site Principal Investigator for the NIH-funded NeuroNEXT clinical trial network.
• Steve Pasternak
  • Scientist, Robarts Research Institute
  • Director, Cognitive Neurology and Alzheimer’s Disease Research Centre, Parkwood Institute
  • SB Massachusetts Institute of Technology Chemical Engineering
  • SB Massachusetts Institute of Technology Life Sciences
  • MD CM McGill University
  • PhD McGill University
  • FRCP(C) (Neurology)June 1995, McGill University Faculty of Medicine
  • His clinic at the Cognitive Neurology and Alzheimer’s Disease Research Centre at Parkwood Hospital I specialize in the diagnosis and treatment of Neurodegenerative diseases, with a focus on Alzheimer’s disease, Lewy Body Disease, Parkinson’s Disease Dementia
  • Launched a Phase 2 Clinical Trial of Ambroxol in Parkinson’s Disease Dementia, and participate in academic and industry-sponsored clinical trials.